Form 8-K - Current report:
SEC Accession No. 0000950170-22-021598
Filing Date
2022-11-03
Accepted
2022-11-03 09:05:21
Documents
13
Period of Report
2022-11-03
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20221103.htm   iXBRL 8-K 69887
2 EX-99.1 acet-ex99_1.htm EX-99.1 42089
  Complete submission text file 0000950170-22-021598.txt   243785

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20221103.xsd EX-101.SCH 2472
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20221103_pre.xml EX-101.PRE 10289
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20221103_lab.xml EX-101.LAB 14018
7 EXTRACTED XBRL INSTANCE DOCUMENT acet-20221103_htm.xml XML 4933
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 221356461
SIC: 2834 Pharmaceutical Preparations